Data Provides Strong Evidence For Continued Value Of Combined Pap And HPV Testing

News — By on April 18, 2009 at 3:59 am

VENLO, The Netherlands, March 24, 2009 /PRNewswire via COMTEX/ — Physicians from Kaiser Permanente and the National Cancer Institute report in the March issue of Obstetrics & Gynecology that results from an evaluation of more than 800,000 Pap and HPV tests conducted at Northern California Kaiser Permanente dispel the notion that excessive numbers of women would require increased surveillance and follow-up when HPV testing is implemented. Cervical cancer is a preventable cancer with a primary known cause — the human papillomavirus (HPV). QIAGEN developed and markets the digene(R) HPV Test, a cervical cancer screening test that detects the high-risk types of HPV that cause cervical cancer and identify women most at risk for dev…

Please read the complete article and let us know what you think below.

Leave a Reply

Trackbacks

Leave a Trackback